SEC Tracker
Get the app
Person · CIK 1914448

Eliana Clark

EVP at Intellia Therapeutics

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Sold on Form 4$690K
Noticed on Form 144$961K
Bought on Form 4$0
Companies1

Holdings now

As reported after the latest Form 3, 4 or 5 at each company.

How these figures work

Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.

CompanySecurityHeldShares or unitsAs of
Intellia Therapeutics NTLACommon StockDirectly93,864Mar 2, 2026 · Filing · EDGAR
Intellia Therapeutics NTLAStock Option (right to buy)
exercise $13.78, expires Feb 29, 2036, into Common Stock
Directly10,505Mar 1, 2026 · Filing · EDGAR

Sold and noticed by quarter

Eliana Clark: dollars sold on Form 4 and noticed on Form 144 per quarter, Q3 2022 to Q4 2026$736K$0Q3 2022: notice not machine-readableQ3 2022: $5K sold on Form 4Q4 2022: $0 noticed on Form 144Q4 2022: $0 sold on Form 4Q1 2023: notice not machine-readableQ1 2023: $71K sold on Form 4Q2 2023: $225K noticed on Form 144Q2 2023: $225K sold on Form 4Q3 2023: $0 noticed on Form 144Q3 2023: $15K sold on Form 4Q4 2023: $0 noticed on Form 144Q4 2023: $0 sold on Form 4Q1 2024: $0 noticed on Form 144Q1 2024: $156K sold on Form 4Q2 2024: $0 noticed on Form 144Q2 2024: $0 sold on Form 4Q3 2024: $0 noticed on Form 144Q3 2024: $9K sold on Form 4Q4 2024: $0 noticed on Form 144Q4 2024: $0 sold on Form 4Q1 2025: $0 noticed on Form 144Q1 2025: $103K sold on Form 4Q2 2025: $0 noticed on Form 144Q2 2025: $0 sold on Form 4Q3 2025: $0 noticed on Form 144Q3 2025: $10K sold on Form 4Q4 2025: $0 noticed on Form 144Q4 2025: $0 sold on Form 4Q1 2026: $0 noticed on Form 144Q1 2026: $96K sold on Form 4Q2 2026: $0 noticed on Form 144Q2 2026: $0 sold on Form 4Q3 2026: $0 noticed on Form 144Q3 2026: $0 sold on Form 4Q4 2026: $736K noticed on Form 144Q4 2026: $0 sold on Form 4Q3 2022Q3 2023Q3 2024Q3 2025Q3 2026

Sold (Form 4) Noticed (Form 144) Bought (Form 4)

Quarterly totals as a table
QuarterSold (Form 4)Noticed (Form 144)
Q4 2026—$736K
Q1 2026$96K—
Q3 2025$10K—
Q1 2025$103K—
Q3 2024$9K—
Q1 2024$156K—
Q3 2023$15K—
Q2 2023$225K$225K
Q1 2023$71KNot machine-readable
Q3 2022$5KNot machine-readable

Form 144 notices went onto EDGAR as structured data on April 13, 2023. Earlier notices were filed on paper and cannot be read here, so those quarters show no noticed amount.

Planned sales (Form 144) and the sales that followed

Each Form 144 notice of a planned sale, grouped by broker and 10b5-1 plan, with the Form 4 sales we matched to it.

How we match

A Form 144 is a notice of a planned sale by an affiliate. SEC Tracker matches each notice to Form 4 sales by the same person at the same company within 90 days of the notice, up to the shares noticed. The match is our inference, not something either filing states.

Notice dateNoticedPlanned saleOutcomeLinks
Intellia Therapeutics NTLA · Morgan Stanley Smith Barney · No 10b5-1 plan stated · 1 notice
Oct 5, 202657,750 · ~$736KOct 5, 2026Not sold yetFiling · EDGAR
Intellia Therapeutics NTLA · E*Trade Financial · 10b5-1 plan adopted Mar 21, 2023 · 1 notice
Jun 20, 20235,000 · ~$225KJun 20, 2023Sold as noticed Sold 5,000 at $45.00 on Jun 20 · $225K Form 4Filing · EDGAR
Sales without a matching Form 144 · 14 sales
No matching Form 144 found. Not every sale needs one: small sales and sales by people who are not affiliates are exempt.
———Sold without notice Intellia Therapeutics (NTLA): Sold 607 at $13.78 on Mar 2, 2026 · $8KFiling · EDGAR
———Sold without notice Intellia Therapeutics (NTLA): Sold 9,515 at $9.21 on Jan 5, 2026 · $88KFiling · EDGAR
———Sold without notice Intellia Therapeutics (NTLA): Sold 1,022 at $9.82 on Jul 1, 2025 · $10KFiling · EDGAR
———Sold without notice Intellia Therapeutics (NTLA): Sold 679 at $8.99 on Mar 4, 2025 · $6KFiling · EDGAR
———Sold without notice Intellia Therapeutics (NTLA): Sold 7,422 at $12.18 on Jan 3, 2025 · $90KFiling · EDGAR
———Sold without notice Intellia Therapeutics (NTLA): Sold 556 at $12.03 on Jan 2, 2025 · $7KFiling · EDGAR
———Sold without notice Intellia Therapeutics (NTLA): Sold 405 at $22.93 on Jul 1, 2024 · $9KFiling · EDGAR
———Sold without notice Intellia Therapeutics (NTLA): Sold 605 at $32.99 on Mar 4, 2024 · $20KFiling · EDGAR
———Sold without notice Intellia Therapeutics (NTLA): Sold 4,301 at $29.46 on Jan 3, 2024 · $127KFiling · EDGAR
———Sold without notice Intellia Therapeutics (NTLA): Sold 307 at $30.12 on Jan 3, 2024 · $9KFiling · EDGAR
———Sold without notice Intellia Therapeutics (NTLA): Sold 360 at $40.51 on Jul 3, 2023 · $15KFiling · EDGAR
———Notice not machine-readable Intellia Therapeutics (NTLA): Sold 1,692 at $37.21 on Jan 4, 2023 · $63KFiling · EDGAR
———Notice not machine-readable Intellia Therapeutics (NTLA): Sold 231 at $34.48 on Jan 3, 2023 · $8KFiling · EDGAR
———Notice not machine-readable Intellia Therapeutics (NTLA): Sold 105 at $51.74 on Jul 1, 2022 · $5KFiling · EDGAR

Every transaction, by company

Each Form 3, 4 and 5 transaction in plain words, newest first.

How these figures work

Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.

Intellia Therapeutics NTLA EVP, Chief Technical Officer · filings 2022 to 2026 · sold $690K · $961K noticed on Form 144

DateTransactionSharesPriceValueHeld afterSource
Mar 2, 2026Open-market or private sale−607$13.78$8K93,864 directFiling · EDGAR
Mar 1, 2026Grant or award from the company+7,35394,471 directFiling · EDGAR
Mar 1, 2026Grant or award from the company
Stock Option (right to buy)
+10,50510,505 directFiling · EDGAR
Jan 5, 2026Open-market or private sale−9,515$9.21$88K87,118 directFiling · EDGAR
Jul 1, 2025Open-market or private sale−1,022$9.82$10K95,369 directFiling · EDGAR
Mar 4, 2025Open-market or private sale−679$8.99$6K95,369 directFiling · EDGAR
Mar 1, 2025Grant or award from the company+32,00096,048 directFiling · EDGAR
Mar 1, 2025Grant or award from the company
Stock Option (right to buy)
+45,71445,714 directFiling · EDGAR
Jan 3, 2025Open-market or private sale−7,422$12.18$90K64,048 directFiling · EDGAR
Jan 2, 2025Open-market or private sale−556$12.03$7K71,470 directFiling · EDGAR
Jul 1, 2024Open-market or private sale−405$22.93$9K71,470 directFiling · EDGAR
Mar 4, 2024Open-market or private sale−605$32.99$20K71,470 directFiling · EDGAR
Mar 1, 2024Grant or award from the company+31,23072,075 directFiling · EDGAR
Mar 1, 2024Grant or award from the company
Stock Option (right to buy)
+45,07245,072 directFiling · EDGAR
Jan 3, 2024Open-market or private sale−307$30.12$9K45,146 directFiling · EDGAR
Jan 3, 2024Open-market or private sale−4,301$29.46$127K40,845 directFiling · EDGAR
Jul 3, 2023Open-market or private sale−360$40.51$15K45,146 directFiling · EDGAR
Jun 20, 2023Option or RSU exercised or converted+5,000$12.27$61K50,146 directFiling · EDGAR
Jun 20, 2023Sale under a 10b5-1 plan−5,000$45.00$225K45,146 directFiling · EDGAR
Jun 20, 2023Option or RSU exercised or converted
Stock Option (right to buy)
−5,00057,750 directFiling · EDGAR
Mar 1, 2023Grant or award from the company+24,53939,012 directFiling · EDGAR
Mar 1, 2023Grant or award from the company+6,13445,146 directFiling · EDGAR
Mar 1, 2023Grant or award from the company
Stock Option (right to buy)
+34,67434,674 directFiling · EDGAR
Jan 4, 2023Open-market or private sale−1,692$37.21$63K14,473 directFiling · EDGAR
Jan 3, 2023Open-market or private sale−231$34.48$8K16,165 directFiling · EDGAR
Jul 1, 2022Open-market or private sale−105$51.74$5K16,165 directFiling · EDGAR
Mar 1, 2022Grant or award from the company+10,52716,165 directFiling · EDGAR
Mar 1, 2022Grant or award from the company
Stock Option (right to buy)
+15,39515,395 directFiling · EDGAR
All 16 Forms 3, 4, 5 and 144
FiledFormCompanyLinks
Oct 5, 2026Form 144Intellia Therapeutics NTLAFiling · EDGAR
Mar 3, 2026Form 4Intellia Therapeutics NTLAFiling · EDGAR
Jan 7, 2026Form 4Intellia Therapeutics NTLAFiling · EDGAR
Jul 3, 2025Form 4Intellia Therapeutics NTLAFiling · EDGAR
Mar 4, 2025Form 4Intellia Therapeutics NTLAFiling · EDGAR
Jan 6, 2025Form 4Intellia Therapeutics NTLAFiling · EDGAR
Jul 3, 2024Form 4Intellia Therapeutics NTLAFiling · EDGAR
Mar 5, 2024Form 4Intellia Therapeutics NTLAFiling · EDGAR
Jan 5, 2024Form 4Intellia Therapeutics NTLAFiling · EDGAR
Jul 6, 2023Form 4Intellia Therapeutics NTLAFiling · EDGAR
Jun 22, 2023Form 4Intellia Therapeutics NTLAFiling · EDGAR
Jun 20, 2023Form 144Intellia Therapeutics NTLAFiling · EDGAR
Mar 3, 2023Form 4Intellia Therapeutics NTLAFiling · EDGAR
Jan 6, 2023Form 4Intellia Therapeutics NTLAFiling · EDGAR
Mar 7, 2022Form 4Intellia Therapeutics NTLAFiling · EDGAR
Mar 7, 2022Form 3Intellia Therapeutics NTLAFiling · EDGAR

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.

Data on this page was fetched . The filing on SEC.gov is the record.